Courses & Events
Accelerating Innovation in Bio-sciences from Hong Kong: Perspectives of a Serial Entrepreneur
Tuesday, May 13, 2025
04:30 pm - 05:50 pm
In this session, Kingsley Leung, Chairman of Uni-Bio Science Group and Co-founder of Great Bay Bio, will share his journey as a serial entrepreneur in the life sciences sector. He will reflect on lessons in entrepreneurial leadership, discuss how Uni-Bio Science has grown into a key enabler for go-to-market strategies in biopharma, and offer insights into the evolving startup and innovation landscape of Hong Kong and the Greater Bay Area—one of Asia’s emerging biotech hubs.
Our seminars will be offered in a hybrid format.
Registration:
- To attend in-person, please register on Eventbrite here.
- To attend by Zoom, please register here.
Details
Agenda:
- 4:30 pm – 5:50 pm Discussion and Audience Q&A | 5:50 – 6:30 pm Networking over light refreshments
Venue:
- Stanford University, Bishop Auditorium, 518 Memorial Way, Stanford, CA 94305 [Google Map]
Parking options:
- Memorial Way, Stanford, CA 94305 [Google Map]
- Lasuen St. and Roth Way, Stanford, CA 94305 [Google Map]
- Please check parking signs carefully to ensure that permitted parking (A or C) and metered spaces are free after 4:00 pm. Paid parking is enforced around The Oval until 6:00 pm.
Speakers
Kingsley Leung
Chairman, Uni-Bio Science Group, Ltd. and Chairman & Co-founder, Great Bay Bio
Mr. Leung has over 15 years’ experience in the life science and finance industries. Currently, he is the Chairman of Uni-Bio Science Group and also serves as Director in both Great Bay Bio and DotBio. He has broad experience in sourcing, evaluating and executing new growth opportunities, supporting the execution and alliance management of 8 deals, including the in-licensing of next generation oncology, inflammation and respiratory drugs from MNCs.
Mr. Leung also has extensive experience in the finance industry where he worked in healthcare investment banking in Merrill Lynch and a family office, helping evaluated IPO opportunities for multiple companies across the US and PRC. Up to date, Mr. Leung has led and successfully raised over USD60M across multiple of his ventures. Mr. Leung was awarded the prestigious honour of World Outstanding Young Leaders Award from Yazhou Zhoukan in 2016, Entrepreneur of the Year from CAPITAL in 2017, Young Industrialist Awards of Hong Kong in 2020, and Gen.T Social Impact and Leader of Tomorrow 2021. Mr. Leung is currently a Chartered Financial Analyst and a member of The Hong Kong Society of Financial Analysts. He was also elected the Vice Chairman of Pharmaceutical & Chemical group of the Federation of Hong Kong Industries (FHKI). Mr. Leung holds a BSc in Biochemistry from Imperial College London, an MSc in Pharmacology from the University of Oxford, and EMBA from Tsinghua-INSEAD. In addition, he holds a Professional Diploma in Corporate Governance & Directorship from the HongKong Institute of Directors.
